These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33935538)

  • 21. Follicular Graft Vs Host Reaction: A Rare Presentation.
    Vashisht D; Kothari R; Baveja S; Neema S; Sengupta P; Sandhu S
    Indian Dermatol Online J; 2020; 11(6):988-990. PubMed ID: 33344353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic and immunophenotypic features of cutaneous solid organ transplant-associated graft-vs-host disease: Comparison with acute hematopoietic cell transplant-associated graft-vs-host disease and cutaneous drug eruption.
    Russell AJ; Musiek AC; Staser KW; Rosman IS
    J Cutan Pathol; 2021 Dec; 48(12):1480-1488. PubMed ID: 34173980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.
    Couban S; Simpson DR; Barnett MJ; Bredeson C; Hubesch L; Howson-Jan K; Shore TB; Walker IR; Browett P; Messner HA; Panzarella T; Lipton JH;
    Blood; 2002 Sep; 100(5):1525-31. PubMed ID: 12176866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
    Olson KA; West K; McCarthy PL
    Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratinocyte apoptosis following bone marrow transplantation: evidence for CTL-dependent and -independent pathways.
    Jerome KR; Conyers SJ; Hansen DA; Zebala JA
    Bone Marrow Transplant; 1998 Aug; 22(4):359-66. PubMed ID: 9722071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
    Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR
    Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.
    Jacoby E; Chen A; Loeb DM; Gamper CJ; Zambidis E; Llosa NJ; Huo J; Cooke KR; Jones R; Fuchs E; Luznik L; Symons HJ
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):112-8. PubMed ID: 26343947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
    Darmstadt GL; Donnenberg AD; Vogelsang GB; Farmer ER; Horn TD
    J Invest Dermatol; 1992 Oct; 99(4):397-402. PubMed ID: 1401996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
    Gallardo D; de la Cámara R; Nieto JB; Espigado I; Iriondo A; Jiménez-Velasco A; Vallejo C; Martín C; Caballero D; Brunet S; Serrano D; Solano C; Ribera JM; de la Rubia J; Carreras E
    Haematologica; 2009 Sep; 94(9):1282-8. PubMed ID: 19734420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.
    Socié G; Sélimi F; Sedel L; Frija J; Devergie A; Esperou Bourdeau H; Ribaud P; Gluckman E
    Br J Haematol; 1994 Mar; 86(3):624-8. PubMed ID: 8043445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
    Slavin S; Morecki S; Weiss L; Or R
    J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
    Horn TD; Altomonte V; Vogelsang G; Kennedy MJ
    J Am Acad Dermatol; 1996 Mar; 34(3):413-7. PubMed ID: 8609251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL; Bloom EJ
    Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients.
    Auberger J; Clausen J; Kircher B; Kropshofer G; Lindner B; Nachbaur D
    Eur J Haematol; 2011 Dec; 87(6):531-8. PubMed ID: 21848700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal tract and liver graft-versus-host disease in pediatric patients with hematopoietic progenitor cell transplantation at a tertiary care center in Mexico.
    Jaramillo-Esparza CM; Consuelo-Sánchez A; Acosta-Rodríguez-Bueno CP; Ramón-García G; Sadowinski-Pine SW; Escobar-Sánchez MA; Castorena-Villa I; Gaytán-Morales F; Vázquez-Frias R
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):385-392. PubMed ID: 29486973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center.
    Scaraficci AC; Fernandes PM; Abreu Alves F; Filho JS; Jaguar GC
    Support Care Cancer; 2022 Jan; 30(1):567-573. PubMed ID: 34341851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and epidemiological analysis of bone marrow transplantation in a pediatric oncology unit].
    de Castro CG; Gregianin LJ; Brunetto AL
    J Pediatr (Rio J); 2003; 79(5):413-22. PubMed ID: 14557841
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.